Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

Ian Chapman, Hugh Greville, Peter Robert Ebeling, Susannah Jane King, Tom C Kotsimbos, Patricia Nugent, Rosie Player, Duncan J Topliss, Janet Warner, John W Wilson

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Abstract

Reduced bone mineral density (BMD) and increased rates of atraumatic fracture are observed in cystic fibrosis (CF) patients, causing increasing morbidity as this population ages. The study aimed to assess the safety, tolerability and effect on BMD of intravenous zoledronate in adults with CF and osteopenia.
Original languageEnglish
Pages (from-to)838 - 846
Number of pages9
JournalClinical Endocrinology
Volume70
Issue number6
DOIs
Publication statusPublished - 2009

Cite this

Chapman, Ian ; Greville, Hugh ; Ebeling, Peter Robert ; King, Susannah Jane ; Kotsimbos, Tom C ; Nugent, Patricia ; Player, Rosie ; Topliss, Duncan J ; Warner, Janet ; Wilson, John W. / Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). In: Clinical Endocrinology. 2009 ; Vol. 70, No. 6. pp. 838 - 846.
@article{cbee18048fd84d22952bc59098511da8,
title = "Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)",
abstract = "Reduced bone mineral density (BMD) and increased rates of atraumatic fracture are observed in cystic fibrosis (CF) patients, causing increasing morbidity as this population ages. The study aimed to assess the safety, tolerability and effect on BMD of intravenous zoledronate in adults with CF and osteopenia.",
author = "Ian Chapman and Hugh Greville and Ebeling, {Peter Robert} and King, {Susannah Jane} and Kotsimbos, {Tom C} and Patricia Nugent and Rosie Player and Topliss, {Duncan J} and Janet Warner and Wilson, {John W}",
year = "2009",
doi = "10.1111/j.1365-2265.2008.03434.x",
language = "English",
volume = "70",
pages = "838 -- 846",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "6",

}

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). / Chapman, Ian; Greville, Hugh; Ebeling, Peter Robert; King, Susannah Jane; Kotsimbos, Tom C; Nugent, Patricia; Player, Rosie; Topliss, Duncan J; Warner, Janet; Wilson, John W.

In: Clinical Endocrinology, Vol. 70, No. 6, 2009, p. 838 - 846.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

AU - Chapman, Ian

AU - Greville, Hugh

AU - Ebeling, Peter Robert

AU - King, Susannah Jane

AU - Kotsimbos, Tom C

AU - Nugent, Patricia

AU - Player, Rosie

AU - Topliss, Duncan J

AU - Warner, Janet

AU - Wilson, John W

PY - 2009

Y1 - 2009

N2 - Reduced bone mineral density (BMD) and increased rates of atraumatic fracture are observed in cystic fibrosis (CF) patients, causing increasing morbidity as this population ages. The study aimed to assess the safety, tolerability and effect on BMD of intravenous zoledronate in adults with CF and osteopenia.

AB - Reduced bone mineral density (BMD) and increased rates of atraumatic fracture are observed in cystic fibrosis (CF) patients, causing increasing morbidity as this population ages. The study aimed to assess the safety, tolerability and effect on BMD of intravenous zoledronate in adults with CF and osteopenia.

UR - http://www3.interscience.wiley.com/cgi-bin/fulltext/121421127/PDFSTART

U2 - 10.1111/j.1365-2265.2008.03434.x

DO - 10.1111/j.1365-2265.2008.03434.x

M3 - Article

VL - 70

SP - 838

EP - 846

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 6

ER -